| Utestående aktier | 543,712,972 shares |
| Insideraktier | 92 480 485 shares |
| Insynsägande | 17,01 % |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Sorrento Therapeutics, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SRNEQ / Sorrento Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i SRNEQ / Sorrento Therapeutics, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-20 | 2023-03-17 | 4 | Ji Henry By BioVintage, Inc. | SRNEQ | Common Stock | I | 0,8027 | 19 500 | 16 | 20 000 | ||||
| 2023-02-06 | 2021-03-15 | 5 | Janda Kim | SRNE | Common Stock | D | 10,4243 | −3 000 | −31 | 0 | ||||
| 2022-12-23 | 2022-12-21 | 4 | Ji Henry By BioVintage, Inc. | SRNE | Common Stock | I | 5,5000 | 300 | 2 | 500 | ||||
| 2022-12-23 | 2022-12-02 | 4 | Ji Henry By BioVintage, Inc. | SRNE | Common Stock | I | 5,5000 | 200 | 1 | 200 | ||||
| 2022-12-16 | 2022-12-15 | 4 | Ji Henry | SRNE | Common Stock | D | 1 500 000 | 6 265 805 | ||||||
| 2022-09-07 | 2022-09-07 | 4 | Ji Henry | SRNE | Common Stock | D | 2,0177 | 88 888 | 179 | 4 765 805 | ||||
| 2022-09-06 | 2022-09-06 | 4 | Ji Henry | SRNE | Common Stock | D | 1,9599 | 55 555 | 109 | 4 676 917 | ||||
| 2022-09-02 | 2022-09-02 | 4 | Ji Henry | SRNE | Common Stock | D | 2 500 000 | 4 621 362 | ||||||
| 2022-08-26 | 2022-08-26 | 4 | Ji Henry | SRNE | Common Stock | D | 2,1100 | 33 333 | 70 | 2 121 362 | ||||
| 2022-08-25 | 2022-08-25 | 4 | Ji Henry | SRNE | Common Stock | D | 2,0596 | 22 222 | 46 | 2 088 029 | ||||
| 2022-06-14 | 2022-06-14 | 4 | Ji Henry | SRNE | Common Stock | D | 1,3999 | 10 000 | 14 | 2 065 807 | ||||
| 2022-05-20 | 2022-05-18 | 4 | CZEREPAK ELIZABETH | SRNE | Stock Option (right to buy) | D | 1,51 | 350 000 | 350 000 | |||||
| 2022-05-20 | 2022-05-18 | 4 | Reilly Tammy | SRNE | Stock Option (right to buy) | D | 1,51 | 100 000 | 100 000 | |||||
| 2021-12-27 | 2021-12-27 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 4,00 | −3 000 | 0 | |||||
| 2021-12-27 | 2021-12-27 | 4 | Janda Kim | SRNE | Common Stock | D | 5,8800 | −3 000 | −18 | 3 000 | ||||
| 2021-12-27 | 2021-12-27 | 4 | Janda Kim | SRNE | Common Stock | D | 4,0000 | 3 000 | 12 | 6 000 | ||||
| 2021-11-18 | 2021-11-18 | 4 | CZEREPAK ELIZABETH | SRNE | Stock Option (right to buy) | D | 6,01 | 100 000 | 100 000 | |||||
| 2021-09-29 | 2021-09-29 | 4 | Ji Henry | SRNE | Non-qualified stock options | D | 4,00 | −10 000 | 0 | |||||
| 2021-09-29 | 2021-09-29 | 4 | Ji Henry | SRNE | Common Stock | D | 4,0000 | 10 000 | 40 | 2 055 807 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Stock Options | D | 3,57 | −7 357 | 27 643 | |||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Stock Options | D | 1,80 | −35 000 | 0 | |||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Common Stock | D | 8,0204 | −42 357 | −340 | 3 000 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Common Stock | D | 3,5700 | 7 357 | 26 | 45 357 | ||||
| 2021-09-28 | 2021-09-27 | 4 | Janda Kim | SRNE | Common Stock | D | 1,8000 | 35 000 | 63 | 38 000 | ||||
| 2021-09-14 | 2021-09-13 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 3,50 | −8 000 | 0 | |||||
| 2021-09-14 | 2021-09-13 | 4 | Janda Kim | SRNE | Common Stock | D | 8,0356 | −8 000 | −64 | 3 000 | ||||
| 2021-09-14 | 2021-09-13 | 4 | Janda Kim | SRNE | Common Stock | D | 3,5000 | 8 000 | 28 | 11 000 | ||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Stock Options | D | 4,89 | −100 000 | 0 | |||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Stock Options | D | 3,95 | −75 000 | 0 | |||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Common Stock | D | 4,8900 | 100 000 | 489 | 235 000 | ||||
| 2021-09-03 | 2021-09-03 | 4 | Smith Robin L | SRNE | Common Stock | D | 3,9500 | 75 000 | 296 | 135 000 | ||||
| 2021-08-30 | 2021-08-30 | 4 | Ji Henry | SRNE | Stock option (right to buy) | D | 8,86 | 2 500 000 | 2 500 000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Smith Robin L | SRNE | Stock option (right to buy) | D | 8,86 | 250 000 | 250 000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Wu Yue Alexander | SRNE | Stock option (right to buy) | D | 8,86 | 250 000 | 250 000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | SHAH JAISIM | SRNE | Stock option (right to buy) | D | 8,86 | 250 000 | 250 000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Janda Kim | SRNE | Stock option (right to buy) | D | 8,86 | 250 000 | 250 000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Lemus David | SRNE | Stock option (right to buy) | D | 8,86 | 250 000 | 250 000 | |||||
| 2021-08-30 | 2021-08-30 | 4 | Followwill Dorman | SRNE | Stock option (right to buy) | D | 8,86 | 250 000 | 250 000 | |||||
| 2021-04-15 | 2021-04-12 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 3,50 | −1 900 | 0 | |||||
| 2021-04-15 | 2021-04-12 | 4 | Janda Kim | SRNE | Common Stock | D | 6,9742 | −1 900 | −13 | 3 000 | ||||
| 2021-04-15 | 2021-04-12 | 4 | Janda Kim | SRNE | Common Stock | D | 3,5000 | 1 900 | 7 | 4 900 | ||||
| 2021-03-17 | 2021-03-16 | 4 | Asghar Najjam | SRNE | Stock Option | D | 10,18 | 100 000 | 100 000 | |||||
| 2021-03-17 | 2021-03-16 | 4 | Asghar Najjam | SRNE | Common Stock | D | 56 974 | 56 974 | ||||||
| 2021-01-26 | 2020-12-16 | 4 | Followwill Dorman | SRNE | Common Stock | D | 7,1350 | −1 000 | −7 | 2 130 | ||||
| 2021-01-26 | 2020-11-11 | 4 | Followwill Dorman | SRNE | Common Stock | D | 1 000 | 3 130 | ||||||
| 2020-11-13 | 2020-11-12 | 4 | Asghar Najjam | SRNE | Stock Option | D | 6,10 | 120 000 | 120 000 | |||||
| 2020-10-20 | 2020-10-16 | 4 | Ji Henry | SRNE | Non-Qualified Stock Option (right to buy) | D | 17,30 | 24 935 882 | 24 935 882 | |||||
| 2020-08-14 | 2020-08-07 | 4 | Janda Kim | SRNE | Stock Options | D | 14,42 | 150 000 | 150 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Smith Robin L | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Ji Henry | SRNE | Stock Options | D | 4,89 | 1 500 000 | 1 500 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Janda Kim | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Followwill Dorman | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Lee Edgar | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Lemus David | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 4,89 | 100 000 | 100 000 | |||||
| 2020-06-15 | 2020-06-15 | 4 | Shao Jiong | SRNE | Stock Options | D | 4,89 | 120 000 | 120 000 | |||||
| 2020-03-05 | 2020-03-05 | 4 | Smith Robin L | SRNE | Common Stock | D | 2,2724 | 40 000 | 91 | 60 000 | ||||
| 2019-12-18 | 3 | Smith Robin L | SRNE | Common Stock | D | 40 000 | ||||||||
| 2019-12-18 | 3 | Smith Robin L | SRNE | Common Stock | D | 40 000 | ||||||||
| 2019-12-18 | 3 | Smith Robin L | SRNE | Common Stock | D | 40 000 | ||||||||
| 2019-12-18 | 2019-12-16 | 4 | Smith Robin L | SRNE | Stock Options | D | 3,95 | 75 000 | 75 000 | |||||
| 2019-12-11 | 2019-12-09 | 4 | Lee Edgar | SRNE | Common Stock | D | 3,81 | 75 000 | 75 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Shao Jiong | SRNE | Stock Options | D | 3,78 | 200 000 | 200 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 3,78 | 70 000 | 70 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Followwill Dorman | SRNE | Stock Options | D | 3,78 | 70 000 | 70 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Ji Henry | SRNE | Stock Options | D | 3,78 | 1 500 000 | 1 500 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Janda Kim | SRNE | Stock Options | D | 3,78 | 70 000 | 70 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | Lemus David | SRNE | Stock Options | D | 3,78 | 70 000 | 70 000 | |||||
| 2019-04-23 | 2019-04-19 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 3,78 | 70 000 | 70 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Followwill Dorman | SRNE | Stock Options | D | 3,57 | 35 000 | 35 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Janda Kim | SRNE | Stock Options | D | 3,57 | 35 000 | 35 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Lemus David | SRNE | Stock Options | D | 3,57 | 35 000 | 35 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 3,57 | 35 000 | 35 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 3,57 | 35 000 | 35 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | Shao Jiong | SRNE | Stock Options | D | 3,57 | 100 000 | 100 000 | |||||
| 2018-11-27 | 2018-11-26 | 4 | ZELDIS JEROME B | SRNE | Stock Options | D | 3,57 | 100 000 | 100 000 | |||||
| 2018-09-14 | 2018-09-13 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 4,9159 | −78 677 | −387 | 1 013 020 | ||||
| 2018-09-14 | 2018-09-13 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 5,0059 | −29 137 | −146 | 1 091 697 | ||||
| 2018-09-14 | 2018-09-12 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 5,0597 | −189 754 | −960 | 1 120 834 | ||||
| 2018-07-23 | 2018-07-20 | 4 | Ji Henry | SRNE | Common Stock | D | 1,75 | −6 000 | 0 | |||||
| 2018-07-23 | 2018-07-20 | 4 | Ji Henry | SRNE | Common Stock | D | 1,7500 | 6 000 | 10 | 2 045 807 | ||||
| 2018-05-17 | 2018-05-17 | 4 | Ji Henry | SRNE | Stock Options | D | 7,20 | 750 000 | 750 000 | |||||
| 2018-02-28 | 2018-02-28 | 4 | Ji Henry | SRNE | Common Stock | D | 9,9500 | 64 600 | 643 | 1 906 177 | ||||
| 2018-02-28 | 2018-02-28 | 4 | Ji Henry | SRNE | Common Stock | I | 124 298 | 260 161 | ||||||
| 2018-02-28 | 2018-02-28 | 4 | Ng George K By Ng Cha Family Trust | SRNE | Common Stock | I | 9,9500 | 90 000 | 895 | 101 453 | ||||
| 2018-02-28 | 2018-02-28 | 4 | Ng George K | SRNE | Common Stock | D | 163 469 | 302 146 | ||||||
| 2018-02-28 | 2018-02-28 | 4 | Ferrigno Dean | SRNE | Common Stock | D | 118 | 245 | ||||||
| 2018-02-08 | 2018-02-07 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock | I | 7,1865 | −150 000 | −1 078 | 1 328 529 | ||||
| 2018-02-08 | 2018-02-06 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock | I | 6,7541 | −512 912 | −3 464 | 1 478 529 | ||||
| 2018-02-07 | 2018-02-05 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 8,0038 | −16 973 | −136 | 1 408 027 | ||||
| 2018-02-07 | 2018-02-05 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 8,0038 | −37 483 | −300 | 3 041 759 | ||||
| 2018-02-07 | 2018-02-05 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 8,0038 | −16 265 | −130 | 1 310 588 | ||||
| 2018-01-31 | 2018-01-30 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 7,6527 | −57 037 | −436 | 1 425 000 | ||||
| 2018-01-31 | 2018-01-30 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 7,6527 | −124 333 | −951 | 3 079 242 | ||||
| 2018-01-31 | 2018-01-30 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 7,6527 | −53 786 | −412 | 1 326 853 | ||||
| 2018-01-31 | 2018-01-29 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 7,6063 | −17 963 | −137 | 1 482 037 | ||||
| 2018-01-31 | 2018-01-29 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 7,6063 | −39 667 | −302 | 3 203 575 | ||||
| 2018-01-31 | 2018-01-29 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 7,6063 | −17 214 | −131 | 1 380 639 | ||||
| 2018-01-25 | 3/A | Ferrigno Dean | SRNE | Common Stock | D | 63 | ||||||||
| 2018-01-25 | 2018-01-24 | 4 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 7,5156 | −577 962 | −4 344 | 8 617 513 | ||||
| 2018-01-25 | 2018-01-23 | 4 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 7,8246 | −106 326 | −832 | 9 195 475 | ||||
| 2018-01-22 | 2018-01-21 | 4 | Ji Henry | SRNE | Common Stock Warrant (right to buy) | D | 8,50 | 261 438 | 261 438 | |||||
| 2018-01-22 | 2018-01-21 | 4 | Ji Henry | SRNE | Common Stock | D | 1 801 801 | 1 841 577 | ||||||
| 2017-11-16 | 2017-11-14 | 4 | Lemus David | SRNE | Stock Options | D | 2,30 | 35 000 | 35 000 | |||||
| 2017-11-16 | 2017-11-14 | 4 | Followwill Dorman | SRNE | Stock Options | D | 2,30 | 35 000 | 35 000 | |||||
| 2017-10-02 | 3 | Followwill Dorman | SRNE | Common Stock | D | 4 260 | ||||||||
| 2017-10-02 | 3 | Followwill Dorman | SRNE | Common Stock | D | 4 260 | ||||||||
| 2017-09-18 | 2017-09-15 | 4/A | SHAH JAISIM | SRNE | Stock Options | D | 1,80 | 35 000 | 35 000 | |||||
| 2017-09-18 | 2017-09-15 | 4/A | Janda Kim | SRNE | Stock Options | D | 1,80 | 35 000 | 35 000 | |||||
| 2017-09-18 | 2017-09-15 | 4/A | Deming David H | SRNE | Stock Options | D | 1,80 | 35 000 | 35 000 | |||||
| 2017-09-18 | 2017-09-15 | 4/A | Wu Yue Alexander | SRNE | Stock Options | D | 1,80 | 35 000 | 35 000 | |||||
| 2017-09-18 | 2017-09-14 | 4 | Ferrigno Dean | SRNE | Stock Options | D | 1,80 | 25 000 | 25 000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | Wu Yue Alexander | SRNE | Stock Options | D | 1,75 | 35 000 | 35 000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 1,75 | 35 000 | 35 000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | Janda Kim | SRNE | Stock Options | D | 1,75 | 35 000 | 35 000 | |||||
| 2017-09-15 | 2017-09-15 | 4 | Deming David H | SRNE | Stock Options | D | 1,75 | 35 000 | 35 000 | |||||
| 2017-09-15 | 2017-09-14 | 4 | ZELDIS JEROME B | SRNE | Stock Options | D | 1,80 | 150 000 | 150 000 | |||||
| 2017-09-15 | 2017-09-14 | 4 | Ng George K | SRNE | Stock Options | D | 1,80 | 150 000 | 150 000 | |||||
| 2017-09-15 | 2017-09-14 | 4 | Ji Henry | SRNE | Stock Options | D | 1,80 | 750 000 | 750 000 | |||||
| 2017-09-15 | 2017-09-11 | 4 | Ng George K | SRNE | Common Stock | D | 89 339 | 138 677 | ||||||
| 2017-09-15 | 2017-09-11 | 4 | Ferrigno Dean | SRNE | Common Stock | D | 64 | 127 | ||||||
| 2017-09-15 | 2017-09-11 | 4 | Ji Henry | SRNE | Common Stock | I | 67 932 | 135 863 | ||||||
| 2017-06-15 | 2017-06-15 | 4 | Ji Henry By spouse | SRNE | Common Stock | I | 1,8400 | 9 000 | 17 | 29 001 | ||||
| 2017-06-15 | 2017-06-15 | 4 | Ji Henry By spouse | SRNE | Common Stock | I | 1,8000 | 20 001 | 36 | 20 001 | ||||
| 2017-06-15 | 2017-06-15 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 1,7900 | 10 002 | 18 | 112 633 | ||||
| 2017-05-19 | 3 | Ferrigno Dean | SRNE | Common Stock | D | 126 | ||||||||
| 2017-05-19 | 3 | Ferrigno Dean | SRNE | Common Stock | D | 126 | ||||||||
| 2017-05-03 | 3 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 18 603 602 | ||||||||
| 2017-05-03 | 3 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 18 603 602 | ||||||||
| 2017-05-03 | 3 | Asia Pacific MedTech (BVI) Ltd | SRNE | Common Stock | D | 18 603 602 | ||||||||
| 2017-04-21 | 2017-04-19 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited See footnote | SRNE | Common Stock | I | 2,0000 | 550 000 | 1 100 | 1 991 441 | ||||
| 2017-04-19 | 2017-04-19 | 4 | Ji Henry | SRNE | Common Stock | D | 2,0000 | 100 000 | 200 | 139 776 | ||||
| 2017-04-17 | 2017-04-13 | 4 | ABG Management Ltd Through ABG Innovation-SO Limited | SRNE | Common Stock | I | 2,0000 | 1 500 000 | 3 000 | 1 500 000 | ||||
| 2017-04-17 | 2017-04-13 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 2,0000 | 1 000 000 | 2 000 | 1 397 853 | ||||
| 2017-02-22 | 2017-02-22 | 4 | Ji Henry | SRNE | Common Stock | D | 5,6000 | 2 000 | 11 | 39 776 | ||||
| 2017-02-10 | 2017-02-10 | 4/A | Ji Henry | SRNE | Common Stock | D | 5,1500 | 20 000 | 103 | 37 776 | ||||
| 2017-02-03 | 2017-02-03 | 4 | ZELDIS JEROME B | SRNE | Common Stock | D | 5,1500 | 10 000 | 52 | 10 000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 5,1500 | 10 000 | 52 | 102 631 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Ng George K | SRNE | Common Stock | D | 5,1500 | −40 000 | −206 | 49 338 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Ji Henry | SRNE | Common Stock | D | 5,1500 | 20 000 | 103 | 37 776 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Herde Kevin | SRNE | Common Stock | D | 5,1500 | 3 000 | 15 | 7 000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Su Jeffrey | SRNE | Common Stock | D | 5,1500 | 4 000 | 21 | 13 000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Janda Kim | SRNE | Common Stock | D | 5,1500 | 3 000 | 15 | 3 000 | ||||
| 2017-02-03 | 2017-02-03 | 4 | Wu Yue Alexander | SRNE | Common Stock | D | 5,1500 | 5 000 | 26 | 5 000 | ||||
| 2017-01-09 | 2017-01-05 | 4 | ABG Management Ltd Through ABG SRNE Limited | SRNE | Common Stock | I | 3 243 242 | 3 243 242 | ||||||
| 2017-01-09 | 2017-01-05 | 4 | ABG Management Ltd Through Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock | I | 1 441 441 | 1 441 441 | ||||||
| 2017-01-09 | 2017-01-05 | 4 | ABG Management Ltd Through ABG II-SO Limited | SRNE | Common Stock | I | 397 853 | 397 853 | ||||||
| 2016-11-15 | 2016-08-12 | 4 | ZELDIS JEROME B | SRNE | Stock Options | D | 6,52 | 200 000 | 200 000 | |||||
| 2016-11-14 | 2016-11-11 | 4 | Ji Henry | SRNE | Stock Options | D | 6,52 | −200 000 | 300 000 | |||||
| 2016-11-09 | 2016-11-08 | 4 | Ng George K | SRNE | Common Stock | D | 89 338 | 90 226 | ||||||
| 2016-11-09 | 2016-11-08 | 4 | Ji Henry | SRNE | Common Stock | I | 67 931 | 67 931 | ||||||
| 2016-08-16 | 2016-08-12 | 4 | Su Jeffrey | SRNE | Stock Options | D | 6,52 | 100 000 | 260 000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Herde Kevin | SRNE | Stock Options | D | 6,52 | 50 000 | 130 000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Ng George K | SRNE | Stock Options | D | 6,52 | 100 000 | 260 000 | |||||
| 2016-08-16 | 2016-08-12 | 4 | Ji Henry | SRNE | Stock Options | D | 6,52 | 500 000 | 977 000 | |||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG II-SO Limited | SRNE | Common Stock, $0.0001 par value | I | 5 480 389 | ||||||||
| 2016-07-15 | 3 | Li Bin By ABG SRNE Limited | SRNE | Common Stock, $0.0001 par value | I | 8 325 778 | ||||||||
| 2016-07-15 | 3 | Li Bin By Ally Bridge LB Healthcare Master Fund Limited | SRNE | Common Stock, $0.0001 par value | I | 6 523 977 | ||||||||
| 2016-07-12 | 2016-07-11 | 4 | Deming David H | SRNE | Stock Options | D | 6,44 | 35 000 | 105 000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | Janda Kim | SRNE | Stock Options | D | 6,44 | 35 000 | 132 400 | |||||
| 2016-07-12 | 2016-07-11 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 6,44 | 35 000 | 305 000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | EBERSOLE DOUGLAS O | SRNE | Stock Options | D | 6,44 | 35 000 | 94 000 | |||||
| 2016-07-12 | 2016-07-11 | 4 | Marth William S | SRNE | Stock Options | D | 6,44 | 49 000 | 182 000 | |||||
| 2016-07-11 | 2016-07-08 | 4 | SOON-SHIONG PATRICK Through Cambridge Equities, LP | SRNE | Warrant | I | 5,80 | −500 000 | 1 224 138 | |||||
| 2016-07-11 | 2016-07-07 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | −7 878 098 | 0 | ||||||
| 2016-07-11 | 2015-07-28 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 720 174 | 7 878 098 | ||||||
| 2016-07-11 | 2015-07-28 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | −720 174 | 0 | ||||||
| 2016-07-01 | 2016-06-29 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 5,8190 | −3 400 | −20 | 7 157 924 | ||||
| 2016-06-24 | 2016-06-23 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 5,8540 | −6 901 | −40 | 7 161 324 | ||||
| 2016-06-17 | 2016-06-15 | 4 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 5,8720 | −19 836 | −116 | 7 168 225 | ||||
| 2016-06-15 | 2016-06-14 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,1140 | −15 972 | −98 | 720 174 | ||||
| 2016-06-15 | 2016-06-13 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,1450 | −37 792 | −232 | 736 146 | ||||
| 2016-04-08 | 3 | Herde Kevin | SRNE | Common Stock | D | 8 000 | ||||||||
| 2016-04-08 | 3 | Herde Kevin | SRNE | Common Stock | D | 8 000 | ||||||||
| 2016-03-15 | 2016-03-11 | 4 | Ji Henry | SRNE | Stock Options | D | 5,79 | 100 000 | 477 000 | |||||
| 2016-03-15 | 2016-03-11 | 4 | Su Jeffrey | SRNE | Stock Options | D | 5,79 | 40 000 | 160 000 | |||||
| 2016-03-15 | 2016-03-11 | 4 | Ng George K | SRNE | Stock Options | D | 5,79 | 40 000 | 160 000 | |||||
| 2016-03-08 | 2016-03-07 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,1700 | −85 300 | −526 | 773 938 | ||||
| 2016-03-08 | 2016-03-04 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 6,3400 | −14 700 | −93 | 859 238 | ||||
| 2016-03-01 | 2015-07-24 | 5 | SOON-SHIONG PATRICK Through The Chan Soon-Shiong Family Foundation | SRNE | Common Stock | I | 7 188 061 | 7 188 061 | ||||||
| 2016-03-01 | 2015-07-24 | 5 | SOON-SHIONG PATRICK Through Cambridge Equities, LP | SRNE | Common Stock | I | −7 188 061 | 0 | ||||||
| 2016-03-01 | 3 | Chan Soon-Shiong Family Foundation | SRNE | Common Stock | D | 14 376 122 | ||||||||
| 2016-03-01 | 3 | Chan Soon-Shiong Family Foundation | SRNE | Common Stock | D | 14 376 122 | ||||||||
| 2015-12-10 | 2015-12-09 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 7,9291 | 39 764 | 315 | 873 938 | ||||
| 2015-12-09 | 2015-12-08 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 8,0110 | 14 000 | 112 | 834 174 | ||||
| 2015-12-09 | 2015-12-07 | 4 | SOON-SHIONG PATRICK | SRNE | Common Stock | D | 7,8909 | 100 000 | 789 | 820 174 | ||||
| 2015-11-02 | 3 | Su Jeffrey | SRNE | Common Stock | D | 18 000 | ||||||||
| 2015-11-02 | 3 | Su Jeffrey | SRNE | Common Stock | D | 18 000 | ||||||||
| 2015-09-21 | 2015-09-18 | 4 | Uy George | SRNE | Common Stock | D | −47 500 | 201 735 | ||||||
| 2015-08-26 | 2015-08-26 | 4 | Ji Henry | SRNE | SRNE 35 March 2016 Call Options | D | 0,5000 | 3 | 0 | 500 | ||||
| 2015-08-26 | 2015-08-26 | 4 | Ji Henry | SRNE | SRNE 35 March 2016 Call Options | D | 0,9500 | 497 | 0 | 497 | ||||
| 2015-08-24 | 2015-08-24 | 4 | Ji Henry | SRNE | Common Stock | D | 12,8430 | 8 888 | 114 | 17 776 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ng George K | SRNE | Common Stock | D | 13,3400 | 55 | 1 | 888 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ng George K | SRNE | Common Stock | D | 13,5460 | 333 | 5 | 833 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ng George K | SRNE | Common Stock | D | 13,4900 | 500 | 7 | 500 | ||||
| 2015-08-21 | 2015-08-21 | 4 | Ji Henry | SRNE | Common Stock | D | 13,0760 | 8 888 | 116 | 14 888 | ||||
| 2015-08-05 | 2015-08-03 | 4 | Ng George K Through Peng Ventures, LLC | SRNE | Common Stock | I | 11,5000 | 11 453 | 132 | 14 901 | ||||
| 2015-08-05 | 2015-08-03 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 11,5000 | 27 189 | 313 | 92 631 | ||||
| 2015-06-08 | 2015-06-04 | 4 | Marth William S | SRNE | Stock Options | D | 13,79 | 58 000 | 133 000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | Janda Kim | SRNE | Stock Options | D | 13,79 | 28 000 | 97 400 | |||||
| 2015-06-08 | 2015-06-04 | 4 | EBERSOLE DOUGLAS O | SRNE | Stock Options | D | 13,79 | 34 000 | 59 000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 13,79 | 25 000 | 270 000 | |||||
| 2015-06-08 | 2015-06-04 | 4 | Deming David H | SRNE | Stock Options | D | 13,79 | 36 000 | 61 000 | |||||
| 2015-05-22 | 2015-05-21 | 4 | Miao Zhenwei | SRNE | Common Stock | D | −40 000 | 559 390 | ||||||
| 2015-05-01 | 2015-04-29 | 4 | Durand Mark | SRNE | Stock Options | D | 8,95 | 120 000 | 145 000 | |||||
| 2015-04-06 | 3/A | Ng George K Through Peng Ventures, LLC | SRNE | Common Stock | I | 3 448 | ||||||||
| 2015-02-26 | 2015-02-24 | 4 | Uy George | SRNE | Stock Options | D | 12,78 | 80 000 | 207 000 | |||||
| 2015-02-26 | 2015-02-24 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 12,78 | 80 000 | 245 000 | |||||
| 2015-02-26 | 2015-02-24 | 4 | Ji Henry | SRNE | Stock Options | D | 12,78 | 160 000 | 377 000 | |||||
| 2015-01-05 | 2015-01-02 | 4 | Ji Henry | SRNE | Common Stock | I | 10,1600 | −10 000 | −102 | 2 043 162 | ||||
| 2015-01-05 | 2014-12-31 | 4 | Ji Henry | SRNE | Common Stock | I | 10,0700 | −15 000 | −151 | 2 053 162 | ||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15 096 296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8 628 409 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8 628 409 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8 628 409 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15 096 296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15 096 296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP Through Cambridge Equities, LP | SRNE | Common Stock | I | 15 096 296 | ||||||||
| 2014-12-29 | 3 | Cambridge Equities, LP | SRNE | Common Stock | D | 8 628 409 | ||||||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8600 | 2 500 | 12 | 16 999 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8500 | 400 | 2 | 14 499 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8400 | 100 | 0 | 14 099 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8100 | 799 | 4 | 13 999 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,8000 | 1 200 | 6 | 13 200 | ||||
| 2014-11-10 | 2014-11-10 | 4 | Ji Henry | SRNE | Common Stock | D | 4,7700 | 1 000 | 5 | 12 000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,6000 | 1 000 | 5 | 11 000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5700 | 1 000 | 5 | 10 000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5500 | 1 000 | 5 | 9 000 | ||||
| 2014-11-07 | 2014-11-07 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5300 | 1 000 | 5 | 8 000 | ||||
| 2014-11-06 | 2014-11-06 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5000 | 1 000 | 4 | 7 000 | ||||
| 2014-11-06 | 2014-11-06 | 4 | Ji Henry | SRNE | Common Stock | D | 4,5500 | 2 000 | 9 | 6 000 | ||||
| 2014-10-09 | 2014-10-07 | 4 | VINCENT RICHARD G | SRNE | Stock Options | D | 4,32 | 50 000 | 270 000 | |||||
| 2014-10-09 | 2014-10-07 | 4 | Ji Henry | SRNE | Stock Options | D | 4,32 | 100 000 | 308 000 | |||||
| 2014-10-09 | 2014-10-07 | 4 | Miao Zhenwei | SRNE | Stock Options | D | 4,32 | 50 000 | 86 000 | |||||
| 2014-09-29 | 2014-09-26 | 4 | Ji Henry | SRNE | Common Stock | I | −20 000 | 2 068 162 | ||||||
| 2014-09-22 | 2014-09-18 | 4 | Janda Kim | SRNE | Stock Options | D | 4,78 | 12 500 | 69 400 | |||||
| 2014-09-22 | 2014-09-18 | 4 | Uy George | SRNE | Stock Options | D | 4,78 | 80 000 | 127 000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | EBERSOLE DOUGLAS O | SRNE | Stock Options | D | 4,78 | 12 000 | 25 000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | Durand Mark | SRNE | Stock Options | D | 4,78 | 12 000 | 25 000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | Marth William S | SRNE | Stock Options | D | 4,78 | 25 000 | 75 000 | |||||
| 2014-09-22 | 2014-09-18 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 4,78 | 25 000 | 165 000 | |||||
| 2014-06-09 | 2014-06-05 | 4 | Ji Henry | SRNE | Common Stock | I | −250 000 | 2 088 162 | ||||||
| 2014-04-15 | 3 | Miao Zhenwei | SRNE | Common Stock | D | 1 198 780 | ||||||||
| 2014-04-15 | 3 | Miao Zhenwei | SRNE | Common Stock | D | 1 198 780 | ||||||||
| 2014-01-24 | 2014-01-23 | 4 | Gallagher Cam | SRNE | Stock Options | D | 9,82 | 10 000 | 35 000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Salka Michael Scott | SRNE | Stock Options | D | 9,82 | 10 000 | 38 000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Marth William S | SRNE | Stock Options | D | 9,82 | 37 000 | 50 000 | |||||
| 2014-01-24 | 2014-01-23 | 4 | Janda Kim | SRNE | Stock Options | D | 9,82 | 10 000 | 56 900 | |||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5500 | 300 | 3 | 1 727 162 | ||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5400 | 100 | 1 | 1 726 862 | ||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5296 | 100 | 1 | 1 726 762 | ||||
| 2013-12-05 | 2013-12-04 | 4 | Ji Henry | SRNE | Common Stock | D | 8,5275 | 500 | 4 | 1 726 662 | ||||
| 2013-12-05 | 2013-12-05 | 4 | Ji Henry | SRNE | Common Stock | D | 8,9500 | 500 | 4 | 1 728 162 | ||||
| 2013-12-05 | 2013-12-05 | 4 | Ji Henry | SRNE | Common Stock | D | 8,8800 | 500 | 4 | 1 727 662 | ||||
| 2013-11-27 | 2013-11-26 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,5400 | −8 714 | −74 | 2 153 045 | ||||
| 2013-11-27 | 2013-11-25 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,5409 | −12 100 | −103 | 2 161 759 | ||||
| 2013-11-26 | 2013-11-25 | 4 | SHAH JAISIM By Spouse | SRNE | Common Stock | I | 8,6500 | 1 000 | 9 | 65 442 | ||||
| 2013-11-25 | 2013-11-22 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,4990 | −8 471 | −72 | 2 173 859 | ||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Convertible Notes | D | 7,50 | 0 | 0 | |||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Common Stock | D | 7,5000 | 4 842 | 36 | 179 307 | ||||
| 2013-11-22 | 2013-10-29 | 4/A | Uy George | SRNE | Stock Options | D | 8,40 | 47 000 | 47 000 | |||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Convertible Notes | D | 7,25 | 0 | 0 | |||||
| 2013-11-22 | 2013-10-30 | 4/A | Uy George | SRNE | Common Stock | D | 7,2500 | 4 842 | 35 | 179 307 | ||||
| 2013-11-22 | 2013-10-29 | 4/A | Uy George | SRNE | Stock Options | D | 8,40 | 47 000 | 47 000 | |||||
| 2013-11-22 | 2013-11-21 | 4 | Uy George | SRNE | Common Stock | D | 8,5700 | 1 000 | 9 | 184 338 | ||||
| 2013-11-22 | 2013-11-21 | 4 | Uy George | SRNE | Common Stock | D | 8,2500 | 2 000 | 16 | 183 338 | ||||
| 2013-11-22 | 2013-11-22 | 4 | Ji Henry | SRNE | Common Stock | D | 8,4660 | 1 000 | 8 | 1 726 162 | ||||
| 2013-11-22 | 2013-11-21 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,5276 | −4 269 | −36 | 2 182 330 | ||||
| 2013-11-21 | 2013-11-20 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | −16 962 | −148 | 2 186 599 | ||||
| 2013-11-21 | 2013-11-19 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | −100 | −1 | 2 203 561 | ||||
| 2013-11-20 | 2013-11-19 | 4 | SHAH JAISIM | SRNE | Common Stock | D | 9,0000 | 1 000 | 9 | 64 442 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Uy George | SRNE | Common Stock | D | 8,7200 | 1 000 | 9 | 181 338 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Uy George | SRNE | Common Stock | D | 8,5000 | 1 031 | 9 | 180 338 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | 8,6000 | 1 000 | 9 | 1 725 162 | ||||
| 2013-11-20 | 2013-11-19 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | 8,5890 | 1 000 | 9 | 1 724 162 | ||||
| 2013-11-18 | 2013-11-15 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | −2 710 | −24 | 2 203 661 | ||||
| 2013-11-15 | 2013-11-14 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | −1 900 | −17 | 2 206 371 | ||||
| 2013-11-14 | 2013-11-13 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | −13 457 | −118 | 2 208 271 | ||||
| 2013-11-12 | 2013-11-08 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 8,7500 | −2 000 | −18 | 2 221 728 | ||||
| 2013-11-08 | 2013-11-07 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 9,0721 | −5 418 | −49 | 2 223 728 | ||||
| 2013-11-08 | 2013-11-06 | 4 | Opko Health, Inc. | SRNE | Common Stock | D | 9,0300 | −114 962 | −1 038 | 2 229 146 | ||||
| 2013-10-31 | 2013-10-29 | 4 | Salka Michael Scott | SRNE | Stock Options | D | 8,40 | 9 000 | 28 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Uy George | SRNE | Stock Options | D | 8,40 | 47 000 | 47 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | SHAH JAISIM | SRNE | Stock Options | D | 8,40 | 80 000 | 140 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | VINCENT RICHARD G | SRNE | Stock Options | D | 8,40 | 100 000 | 220 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Gallagher Cam | SRNE | Stock Options | D | 8,40 | 9 000 | 25 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Ji Henry | SRNE | Stock Options | D | 8,40 | 101 000 | 117 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Webb David Ritchie | SRNE | Stock Options | D | 8,40 | 11 000 | 29 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Janda Kim | SRNE | Stock Options | D | 8,40 | 9 000 | 46 900 | |||||
| 2013-10-31 | 2013-10-29 | 4 | Trieu Vuong | SRNE | Stock Options | D | 8,40 | 36 000 | 36 000 | |||||
| 2013-10-31 | 2013-10-29 | 4 | AFTING ERNST-GUENTER | SRNE | Stock Options | D | 8,40 | 9 000 | 26 600 | |||||
| 2013-10-23 | 2013-10-21 | 4 | Uy George | SRNE | Convertible Note | D | 35 000,0000 | 0 | 0 | 0 | ||||
| 2013-09-27 | 2013-09-25 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | −2 000 | 1 723 162 | ||||||
| 2013-09-20 | 3 | SHAH JAISIM | SRNE | Common Stock | D | 0 | ||||||||
| 2013-09-19 | 3 | Trieu Vuong | SRNE | Common Stock | D | 3 006 641 | ||||||||
| 2013-09-19 | 3 | Uy George | SRNE | Common Stock | D | 0 | ||||||||
| 2013-09-04 | 2013-09-04 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,0100 | −55 | −0 | 2 344 108 | ||||
| 2013-09-04 | 2013-09-04 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7500 | −9 300 | −72 | 2 344 163 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7500 | −100 | −1 | 2 353 463 | ||||
| 2013-08-28 | 2013-08-28 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7500 | −641 | −5 | 2 353 563 | ||||
| 2013-08-28 | 2013-08-26 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,0000 | −1 615 | −13 | 2 354 204 | ||||
| 2013-08-21 | 2013-08-20 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 7,7788 | −1 560 | −12 | 2 355 819 | ||||
| 2013-08-16 | 2013-08-14 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,9500 | −2 900 | −26 | 2 357 379 | ||||
| 2013-08-15 | 2013-08-07 | 4 | Opko Health, Inc. | OTCQB:SRNE | Common Stock | D | 8,5000 | −331 | −3 | 2 360 279 | ||||
| 2013-07-05 | 2013-07-03 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | −25 000 | 43 129 032 | ||||||
| 2012-10-19 | 2012-09-30 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock option | D | 0,16 | −725 000 | 2 275 000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Webb David Ritchie | SRNE | Non-qualified stock option | D | 0,14 | −37 500 | 0 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Webb David Ritchie | SRNE | Non-qualified stock option | D | 0,16 | 450 000 | 450 000 | |||||
| 2012-10-19 | 2012-09-30 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock option | D | 0,16 | −725 000 | 2 275 000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Salka Michael Scott | SRNE | Non-qualified stock option | D | 0,16 | 400 000 | 400 000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Salka Michael Scott | SRNE | Call option | D | 0,16 | −300 000 | 0 | |||||
| 2012-10-19 | 2012-10-17 | 4 | AFTING ERNST-GUENTER | SRNE | Non-qualified stock option | D | 0,16 | 400 000 | 400 000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Gallagher Cam | SRNE | Non-qualified stock option | D | 0,16 | 400 000 | 400 000 | |||||
| 2012-10-19 | 2012-10-17 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 0,16 | 400 000 | 400 000 | |||||
| 2012-09-25 | 2012-09-22 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock options | D | 0,16 | 3 000 000 | 3 000 000 | |||||
| 2012-09-13 | 3 | Gallagher Cam | SRNE | No securities beneficially owned | D | 0 | ||||||||
| 2012-09-13 | 3 | Webb David Ritchie | SRNE | No securities beneficially owned. | D | 0 | ||||||||
| 2012-07-20 | 2012-07-20 | 4 | Lockshin Curtis | SRNE | Non-qualifed stock option | D | 0,16 | 15 000 | 15 000 | |||||
| 2012-07-20 | 2012-07-20 | 4 | Salka Michael Scott | SRNE | Non-qualified stock options | D | 0,16 | 15 000 | 15 000 | |||||
| 2012-07-20 | 2012-07-20 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 0,16 | 25 000 | 25 000 | |||||
| 2012-07-20 | 2012-07-20 | 4 | Tang-Liu Diane D S | SRNE | Non-qualified stock options | D | 0,16 | 15 000 | 15 000 | |||||
| 2012-05-16 | 2012-05-15 | 4 | SCIFRES DONALD R | SRNE | Call Option (Obligation to Sell) | I | 0,16 | −300 000 | 300 000 | |||||
| 2012-05-16 | 2012-05-15 | 4 | Salka Michael Scott | SRNE | Call Option (right to buy) | D | 0,16 | 300 000 | 300 000 | |||||
| 2012-05-16 | 2012-05-15 | 4 | Ji Henry Footnote 1 | SRNE | Common Stock | I | 0,1600 | 6 250 000 | 1 000 | 6 250 000 | ||||
| 2012-04-03 | 2012-03-30 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | −150 000 | 43 154 032 | ||||||
| 2012-02-28 | 2012-02-23 | 4 | Tang-Liu Diane D S | SRNE | Non-qualified stock options | D | 0,16 | 60 000 | 60 000 | |||||
| 2012-02-27 | 2012-02-23 | 4 | Salka Michael Scott | SRNE | Non-qualified stock options | D | 0,16 | 60 000 | 60 000 | |||||
| 2012-02-27 | 2012-02-23 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | −150 000 | 43 304 032 | ||||||
| 2012-02-27 | 2012-02-23 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | −150 000 | 43 454 032 | ||||||
| 2012-02-27 | 2012-02-23 | 4 | Ji Henry By Trust | SRNE | Common Stock | I | −150 000 | 43 604 032 | ||||||
| 2012-02-09 | 2011-12-29 | 5/A | SCIFRES DONALD R | SRNE | Common Stock | I | 0,1600 | 12 500 000 | 2 000 | 38 844 714 | ||||
| 2012-02-09 | 2011-08-28 | 5/A | SCIFRES DONALD R | SRNE | Common Stock | I | −9 813 880 | 26 344 714 | ||||||
| 2012-02-07 | 2012-02-06 | 4 | Ji Henry | SRNE | Non-qualified stock options | D | 0,16 | 250 000 | 250 000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | VINCENT RICHARD G | SRNE | Non-qualified stock options | D | 0,16 | 125 000 | 125 000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | Lockshin Curtis | SRNE | Non-qualifed stock option | D | 0,16 | 100 000 | 100 000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | Janda Kim | SRNE | Non-qualified stock option | D | 0,16 | 75 000 | 75 000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | HSIAO JANE PH D | SRNE | Non-qualified stock options | D | 0,16 | 75 000 | 75 000 | |||||
| 2012-02-07 | 2012-02-06 | 4 | HALPRYN GLENN L | SRNE | Non-qualified stock option | D | 0,16 | 140 000 | 140 000 | |||||
| 2012-01-06 | 2011-12-29 | 5 | SCIFRES DONALD R | SRNE | Common Stock | I | 0,1600 | 12 500 000 | 2 000 | 48 658 594 | ||||
| 2010-02-26 | 2010-02-05 | 4 | Lockshin Curtis | SRNE | Non-qualifed stock option | D | 0,07 | 15 000 | 55 000 | |||||
| 2010-02-26 | 2010-02-05 | 4 | HALPRYN GLENN L | SRNE | Non-qualified stock option | D | 0,07 | 10 000 | 50 000 | |||||
| 2010-02-05 | 3 | ZANIBONI STEVE | SRNE | Common Stock | D | 25 484 329 | ||||||||
| 2010-01-27 | 3 | HSIAO JANE PH D By partnership | SRNE | Common Stock | I | 2 231 719 | ||||||||
| 2009-09-23 | 3 | Ji Henry | QBSW | Common Stock | D | 1 785 375 | ||||||||
| 2009-09-23 | 3 | Shuster Lewis | QBSW | Common Stock | D | 669 516 | ||||||||
| 2009-09-23 | 3 | AFTING ERNST-GUENTER | QBSW | Common Stock | D | 557 930 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
